# A Study to Evaluate the Amount of Drug That Becomes Available to the Blood Circulation When Inhaled by a Nebulizer and Dry Powder Inhaler in Healthy Subjects.

> **NCT04072562** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 24 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** AZD7594

## Key facts

- **NCT ID:** NCT04072562
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-19
- **Primary completion:** 2019-11-28
- **Final completion:** 2019-11-28
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04072562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04072562, "A Study to Evaluate the Amount of Drug That Becomes Available to the Blood Circulation When Inhaled by a Nebulizer and Dry Powder Inhaler in Healthy Subjects.". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT04072562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*